Eagle Pointome Market Risk Adjusted Performance
| EIC Stock | | | USD 9.60 -0.09 -0.93% |
The Market Risk Adjusted Performance technical lookup provides context for Eagle Pointome and related instruments. Coverage varies by data normalization and availability; see
Equity Screeners for broader screening context. Eagle Pointome has a market cap of 254.54 M, operating margin of 83.6%, ROE of -0.37%. Review
Investing Opportunities for broader portfolio context. This reflects a position in Eagle Pointome within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in gross domestic product.
New to investing in Eagle Stock? Start with our
How to Invest in Eagle Stock guide for a step-by-step overview.
Eagle Pointome has current Market Risk Adjusted Performance of 0.3273.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 0.3273 | |
| ER[a] | = | Expected return on investing in Eagle Pointome |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Eagle Pointome Market Risk Adjusted Performance Peers Comparison
Eagle Market Risk Adjusted Performance Relative To Other Indicators
Eagle Pointome holds the
#2 position for market risk adjusted performance relative to top peers. It is currently under evaluation for maximum drawdown relative to top peers with a Maximum Drawdown-to-Market Risk Adjusted Performance ratio near
23.31 . The Maximum Drawdown to Market Risk Adjusted Performance ratio for Eagle Pointome comes in at
23.31 Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.